Type
Blood Testing
Duration
15 min
Sample
Blood (venous)
What's included
3 deliverables in this treatment
- Venous blood draw (2 × EDTA tubes)
- Next‑generation sequencing of BRCA1 and BRCA2
- Comprehensive results report with variant interpretation and tele‑consultation
A targeted blood test that looks for hereditary mutations in the BRCA1 and BRCA2 genes. It uses a venous draw (2 × EDTA tubes) to assess cancer‑related risk and guide preventive decisions.
About this treatment
The Breast Cancer NGS Panel examines two key DNA repair genes—BRCA1 and BRCA2—using a venous blood sample collected in two EDTA tubes. By sequencing these loci, the test may support identification of inherited variants that are associated with higher breast and ovarian cancer risk, helping clinicians and patients consider surveillance or risk‑reduction strategies. Results are delivered in a detailed report that includes the genetic findings, an interpretation of each variant, and a brief tele‑consultation to discuss next steps. The service covers the blood draw, next‑generation sequencing of the two markers, and the final written report with clinician support.
Good to know
- Sample
- Blood (venous) – 2 × EDTA
- Markers
- 2 (BRCA1, BRCA2)
Who is this for?
Individuals with a family history of breast or ovarian cancer
About the clinic
Reviews, team and credentials
Independent review links and clinic-reported team information.
2,261 clinic reviews
From independent platforms
Treatment highlights
- Venous blood draw (2 × EDTA tubes)
- Next‑generation sequencing of BRCA1 and BRCA2
+1 more item in What's included
2xEDTA. Genetic panel.